Avalo Therapeutics, Inc. ($AVTX)
Sullivan Christopher Ryan โ Chief Financial Officer
Shares
1,780
Price
$17.57
Total Value
$31,269.97
Nearby Earnings
Mar 19, 2026
EPS:Est: -1.46
Mar 23, 2026
EPS:-1.02 (est: -1.46)-29.8%
Revenue:-$209.00K
Transaction Details
| Insider | Sullivan Christopher Ryan |
|---|---|
| Title | Chief Financial Officer |
| Transaction Date | Apr 2, 2026 |
| Transaction Code | S Sale |
| Acquired/Disposed | Disposed |
| Security | Common Stock |
| Direct/Indirect | Direct |
| Filing Date | Apr 3, 2026 |
| Shares Sold | 1,780 |
| Price per Share | $17.57 |
| Total Value | $31,269.97 |
| Shares Owned After | 17,338 |
| Derivative | No |
| Accession Number | 0001810417-26-000006 |
| Document | View SEC Filing |